NCT05180162 - Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 9, 2021

Primary Completion Date

May 28, 2024

Study Completion Date

May 28, 2024

Conditions

Liver FibrosisPulmonary FibrosisMyocardial Fibrosis

Interventions

DRUG

68Ga-FAP-2286

A dose of 3 - 8 millicurie (mCi) will be given intravenously (IV)

PROCEDURE

Positron Emission Tomography (PET)

Imaging will begin 50-100 minutes after injection and last about 45 minutes.

Trial Locations (1)

University of California, San Francisco, San Francisco